A novel epigenetic signature for overall survival prediction in patients with breast cancer

被引:0
作者
Xuanwen Bao
Natasa Anastasov
Yanfang Wang
Michael Rosemann
机构
[1] Helmholtz Center Munich,Institute of Radiation Biology
[2] German Research Center for Environmental Health,Department of Pharmacy, Pharmaceutical Biotechnology, Center of Nanoscience (CeNS)
[3] Technical University Munich (TUM),undefined
[4] Ludwig-Maximilians-Universität München (LMU),undefined
来源
Journal of Translational Medicine | / 17卷
关键词
Breast cancer; Mammary carcinoma; Epigenetics; Molecular marker; Response; Prognosis; Molecular signature; Individualized therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 94 条
[1]  
Reis-Filho JS(2011)Gene expression profiling in breast cancer: classification, prognostication, and prediction Lancet. 378 1812-1823
[2]  
Pusztai L(2015)A DNA methylation-based definition of biologically distinct breast cancer subtypes Mol Oncol 9 555-568
[3]  
Stefansson OA(2016)DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer Nat Commun 7 10478-519
[4]  
Moran S(2015)Comprehensive molecular portraits of invasive lobular breast cancer Cell 163 506-4147
[5]  
Gomez A(2019)Prognostic and predictive value of three DNA methylation signatures in lung adenocarcinoma Front Genet 10 349-15
[6]  
Sayols S(2013)A prognostic DNA methylation signature for stage I non-small-cell lung cancer J Clin Oncol 31 4140-395
[7]  
Arribas-Jorba C(2019)High quality ATAC-Seq data recovered from cryopreserved breast cell lines and tissue Sci Rep 9 516-17407
[8]  
Sandoval J(2019)Low GAS5 levels as a predictor of poor survival in patients with lower-grade gliomas J Oncol 2019 1-287
[9]  
Teschendorff AE(2019)A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis Cancer Cell Int 19 100-1122
[10]  
Gao Y(1997)The lasso method for variable selection in the Cox model Stat Med 16 385-4642